Dutch Bros enters mid-June with an unusual divergence: the founder is selling heavily into strength, yet short sellers are quietly retreating and options traders have turned decisively bullish.
The founder story is the standout this week. Travis Boersma, Executive Chairman and co-founder, sold over $86 million worth of shares across five trading days at the end of May and into June 1 — the largest insider selling cluster visible in recent data. The trades ran from May 27 through June 1, averaging roughly $17 million per day at prices between $56 and $58.30. The institutional picture adds some context: BlackRock added 6.6 million shares in its most recent filing, and FMR (Fidelity) added 4.1 million. The big passive and active money is clearly flowing in a different direction from Boersma. Director Todd Penegor made a small open-market purchase of 2,000 shares at $51.18 on May 15, a modest but positive counter-signal from within the boardroom.
Short sellers have been covering steadily, and the borrow market is loose. SI has fallen 15% over the past month to 13.9% of the free float — still a meaningful level, but the direction of travel matters here. The week-on-week change is a further 1.6% decline. Borrow costs are near their 30-day lows at 0.45%, down from 0.55% in late April. Availability has loosened substantially — now running at 233% of outstanding short interest, well above the 52-week low of 138%, meaning there are more than two shares available to borrow for every one currently shorted. That's a market telling you there's no squeeze pressure and no urgency among new short sellers. The ORTEX short score has drifted lower over the past two weeks, from 66.5 on May 27 to 63.8 now, consistent with a modest unwind rather than any fresh conviction build.
Options traders have made the most decisive move of the week. The put/call ratio has dropped to 0.44 — a full standard deviation below its 20-day average of 0.51 and close to the 52-week low of 0.37. Six weeks ago, the PCR was running above 0.68 with a much more defensive tilt. The shift since early May has been consistent and sharp: traders have rotated away from puts and into calls as the stock climbed 9.6% over the past month to $57.79. That level of call dominance flags real bullish conviction in the options market, not just a mechanical hedge unwind.
The Street is broadly constructive, though valuation is a friction point. The consensus is Buy with 18 buy-rated analysts and a mean target of $76.65 — roughly 33% above the current price. Recent analyst activity has been mostly maintenance: TD Cowen reiterated Buy at $73 on June 10, DA Davidson maintained Buy at $75, and Citigroup nudged its target to $85 from $84 after the May earnings. Barclays trimmed its target by $1 to $75 but kept Overweight. The sole holdout is Piper Sandler at Neutral with a $61 target. On valuation, the trailing P/E is running at 53.8x and EV/EBITDA near 19.9x — the P/E has expanded roughly 4.8 turns over the past month as the stock re-rated. EPS momentum is the bright spot: BROS ranks in the 88th percentile on 30-day forward EPS momentum, and 81st on the 90-day figure. The bull case centres on drive-thru unit economics, rapid expansion, and AI-assisted operations. Bears point to geographic concentration, the co-founder's outsized voting control limiting shareholder influence, and the risk that new store productivity disappoints.
Earnings are next due August 6. The prior two Q1 prints both produced negative day-one reactions — down 10.8% after the May 2026 report and down 6.3% after the comparable Q1 a year prior — though the five-day recovery was positive after the most recent print (+8.7%). With the stock now 33% below the Street's mean target and short sellers continuing to cover, the setup heading into August will depend heavily on whether comparable-store sales momentum holds at the pace of the most recent beat.
See the live data behind this article on ORTEX.
Open BROS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
